The Company has announced a strategic partnership with the Tear Film & Ocular Surface Society (TFOS), an international non-profit organization dedicated to advancing research and education in ocular surface health. The initiative reinforces EssilorLuxottica’s commitment to advancing eye health through science and education, while supporting improved patient care worldwide.

Over the past twenty years, TFOS has played a pioneering role in raising global awareness of external eye diseases, supporting research funding, and driving innovation in treatments, diagnostics, and clinical practices.

This collaboration further strengthens the Company’s leadership in the field and supports impactful research efforts and education programs such as the global TFOS Ambassador Program, which promotes awareness of ocular surface health around the world.

Ocular surface health: a critical lever for better clinical outcomes

Ocular surface disease, particularly dry eye disease, is increasingly recognized as a key factor influencing surgical outcomes. It can affect pre-operative measurements, increase post-operative complications, and ultimately impact visual performance and patient experience.

Addressing these challenges and as part of its commitment to supporting TFOS, EssilorLuxottica is sponsoring the development of a new, evidence-based consensus report titled “Guidelines for Preparing the Ocular Surface for Eye Surgery.” The initiative is aimed at harmonizing perioperative care across a broad spectrum of procedures, including cataract, refractive, glaucoma, retina, and oculoplastic surgeries. Developed by a global panel of leading experts, these guidelines are expected to shape clinical practice and elevate standards of care worldwide.

Driving impact at scale

Espansione Group, part of EssilorLuxottica since 2025, has actively contributed to TFOS’ widely recognized the recently released TFOS Dry Eye Workshop (DEWS) III Report, a global reference for the understanding and management of dry eye disease and ocular surface care, which included Espansione Group’s flagship product eye-light.

TFOS reports, including previous DEWS publications, have reached hundreds of thousands of professionals worldwide and are considered foundational resources in the scientific community. Through this partnership, EssilorLuxottica is strengthening its role in advancing patient-centered, evidence-based eye care solutions while supporting the global scientific ecosystem.

Learn more:

TFOS Diagnostic Methodology Report

TFOS Digest Report

TFOS Management & Therapy Report